Palvella Therapeutics
Quarterly Financials
| Values in thousands | 2024-03-31 |
|---|---|
Revenue | $0 |
Net Income | -2,536 |
Net Change In Cash | 0 |
Free Cash Flow | -1,102 |
Cash | 6,248 |
Basic Shares | 11,221 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | 18,691 | -27,552 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -13,703 | -14,840 |
Cash | 7,350 | 16,053 |
Basic Shares | 11,221 | 11,221 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.18 |
2024-06-30 | -$2.76 |
2024-03-31 | -$3.95 |
2023-12-31 | -$3.70 |
